GW Pharmaceuticals Short ratio
Cos'è Short ratio di GW Pharmaceuticals?
Short ratio di GW Pharmaceuticals è 1.15
Qual è la definizione di Short ratio?
Short ratio è il numero di azioni vendute breve diviso per il volume medio giornaliero.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Short ratio di aziende nel Health Care settore su NASDAQ rispetto a GW Pharmaceuticals
Aziende con short ratio simili a GW Pharmaceuticals
- Uranium Royalty ha Short ratio di 1.14
- Uranium Royalty ha Short ratio di 1.14
- BNY Mellon Municipal Income Inc ha Short ratio di 1.14
- Listed Funds Trust ha Short ratio di 1.14
- Catalent ha Short ratio di 1.14
- Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund ha Short ratio di 1.14
- GW Pharmaceuticals ha Short ratio di 1.15
- Macro Enterprises ha Short ratio di 1.16
- Oceanic Iron Ore ha Short ratio di 1.16
- Scandium International Mining ha Short ratio di 1.16
- Unity Biotechnology Inc ha Short ratio di 1.16
- Helix Applications ha Short ratio di 1.16
- Lincoln National ha Short ratio di 1.16